The National Library of Medicine has announced the departure of Dr. David J. Lipman, who has served as the Director of the National Center for Biotechnology Information (NCBI) since its creation almost 30 years ago. Dr. Lipman is assuming the position of Chief Science Officer at Impossible Foods, a new company applying molecular biology to the food industry.
NCBI creates and maintains a series of databases relevant to biotechnology and biomedicine, and is a world-renowned and trusted resource for bioinformatics tools and services. Major NCBI databases include GenBank for DNA sequences and PubMed, one of the most heavily used sites in the world for the search and retrieval of biomedical information.
Under Dr. Lipman's leadership, NCBI has become an essential resource for biomedical researchers, practitioners, patients as well as the biotechnology and pharmaceutical industries. During his tenure, NCBI has grown from a handful of staff working to link biomedical literature and DNA sequences to a staff of hundreds that produce more than 40 integrated databases that serve scientists and the general public. Each day more than 3 million users access NCBI databases and download more than 50 terabytes of data.
Dr. Lipman has been an advocate for promoting open access to the world's biomedical literature and launched PubMed in 1997, followed by the full-text repository, PubMed Central (PMC), in 2000. He was instrumental in implementing the NIH Public Access Policy whereby NIH-funded papers are made publicly available in PMC.
Brought to you by Scope e-Knowledge Center, a world-leading provider of Abstracting & Indexing (A&I) Services, Knowledge Modeling Services (Taxonomies, Thesauri and Ontologies), Metadata Enrichment & Entity Extraction Services.
